These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35853489)

  • 1. Comparison of Fundus Autofluorescence Versus Optical Coherence Tomography-based Evaluation of the Therapeutic Response to Pegcetacoplan in Geographic Atrophy.
    Mai J; Riedl S; Reiter GS; Lachinov D; Vogl WD; Bogunovic H; Schmidt-Erfurth U
    Am J Ophthalmol; 2022 Dec; 244():175-182. PubMed ID: 35853489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence-Based OCT Analysis.
    Riedl S; Vogl WD; Mai J; Reiter GS; Lachinov D; Grechenig C; McKeown A; Scheibler L; Bogunović H; Schmidt-Erfurth U
    Ophthalmol Retina; 2022 Nov; 6(11):1009-1018. PubMed ID: 35667569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months.
    Fu DJ; Bagga P; Naik G; Glinton S; Faes L; Liefers B; Lima R; Wignall G; Keane PA; Ioannidou E; Ribeiro Reis AP; McKeown A; Scheibler L; Patel PJ; Moghul I; Pontikos N; Balaskas K
    JAMA Ophthalmol; 2024 Jun; 142(6):548-558. PubMed ID: 38722644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.
    Nittala MG; Metlapally R; Ip M; Chakravarthy U; Holz FG; Staurenghi G; Waheed N; Velaga SB; Lindenberg S; Karamat A; Koester J; Ribeiro R; Sadda S
    JAMA Ophthalmol; 2022 Mar; 140(3):243-249. PubMed ID: 35113137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep-learning automated quantification of longitudinal OCT scans demonstrates reduced RPE loss rate, preservation of intact macular area and predictive value of isolated photoreceptor degeneration in geographic atrophy patients receiving C3 inhibition treatment.
    Fu DJ; Glinton S; Lipkova V; Faes L; Liefers B; Zhang G; Pontikos N; McKeown A; Scheibler L; Patel PJ; Keane PA; Balaskas K
    Br J Ophthalmol; 2024 Mar; 108(4):536-545. PubMed ID: 37094835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
    Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.
    Sayegh RG; Simader C; Scheschy U; Montuoro A; Kiss C; Sacu S; Kreil DP; Prünte C; Schmidt-Erfurth U
    Ophthalmology; 2011 Sep; 118(9):1844-51. PubMed ID: 21496928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
    Wykoff CC; Rosenfeld PJ; Waheed NK; Singh RP; Ronca N; Slakter JS; Staurenghi G; Monés J; Baumal CR; Saroj N; Metlapally R; Ribeiro R
    Ophthalmology; 2021 Sep; 128(9):1325-1336. PubMed ID: 33711380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning.
    Vogl WD; Riedl S; Mai J; Reiter GS; Lachinov D; Bogunović H; Schmidt-Erfurth U
    Ophthalmol Retina; 2023 Jan; 7(1):4-13. PubMed ID: 35948209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT.
    Schmidt-Erfurth U; Mai J; Reiter GS; Riedl S; Vogl WD; Sadeghipour A; McKeown A; Foos E; Scheibler L; Bogunovic H
    Ophthalmology; 2024 Aug; ():. PubMed ID: 39151755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
    Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy.
    Simader C; Sayegh RG; Montuoro A; Azhary M; Koth AL; Baratsits M; Sacu S; Prünte C; Kreil DP; Schmidt-Erfurth U
    Am J Ophthalmol; 2014 Sep; 158(3):557-66.e1. PubMed ID: 24879944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Outer Retina En Face OCT Imaging for Geographic Atrophy Progression.
    Giocanti-Auregan A; Tadayoni R; Fajnkuchen F; Dourmad P; Magazzeni S; Cohen SY
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8325-30. PubMed ID: 26747761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Geographic Atrophy Using Spectral Domain OCT in Age-Related Macular Degeneration.
    Cleland SC; Konda SM; Danis RP; Huang Y; Myers DJ; Blodi BA; Domalpally A
    Ophthalmol Retina; 2021 Jan; 5(1):41-48. PubMed ID: 32679202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy.
    Pfau M; Schmitz-Valckenberg S; Ribeiro R; Safaei R; McKeown A; Fleckenstein M; Holz FG
    Sci Rep; 2022 Oct; 12(1):17870. PubMed ID: 36284220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Retinal Thickness and Fundus Autofluorescence in Geographic Atrophy.
    Wang DL; Agee J; Mazzola M; Sacconi R; Querques G; Weinberg AD; Smith RT
    Ophthalmol Retina; 2019 Dec; 3(12):1035-1044. PubMed ID: 31810572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between morphological and vascular alterations in geographic atrophy using a multimodal imaging approach.
    Hecht A; Pollreisz A; Sayegh R; Told R; Baratsits M; Baumann B; Pircher M; Hitzenberger CK; Sacu S; Schmidt-Erfurth U
    Acta Ophthalmol; 2020 Sep; 98(6):e700-e708. PubMed ID: 32067383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Effects of C3 Inhibition on Geographic Atrophy Progression from Deep-Learning OCT Quantification: A Split-Person Study.
    Fu DJ; Lipkova V; Liefers B; Glinton S; Faes L; McKeown A; Scheibler L; Pontikos N; Patel PJ; Zhang G; Keane PA; Balaskas K
    Ophthalmol Ther; 2023 Dec; 12(6):3143-3158. PubMed ID: 37715860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Characteristics of Spectral-Domain Optical Coherence Tomography in Corresponding Areas of Increased Autofluorescence at the Margin of Geographic Atrophy in Patients With Age-Related Macular Degeneration.
    Hariri AH; Nittala MG; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):523-7. PubMed ID: 27327281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLASSIFICATION AND QUANTITATIVE ANALYSIS OF GEOGRAPHIC ATROPHY JUNCTIONAL ZONE USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Qu J; Velaga SB; Hariri AH; Nittala MG; Sadda S
    Retina; 2018 Aug; 38(8):1456-1463. PubMed ID: 28834947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.